Table 4.
Clinical categories of antimicrobial agents reported by the participating centres by family of carbapenemase-producing microorganisms.
| Enterobacterales | P. aeruginosa | |||||
|---|---|---|---|---|---|---|
| % R | % I | % S | % R | % I | % S | |
| Piperacillin-tazobactam | 96.7% | 1.7% | 1.6% | 85.1% | 7.8% | 7.1% |
| Cefotaxime | 93.5% | 1.2% | 5.3% | -- | -- | -- |
| Ceftazidime | 91.3% | 0.8% | 7.9% | 90.5% | 4.9% | 4.6% |
| Cefepime | 87.3% | 4.5% | 8.2% | 90.8% | 5.2% | 4% |
| Aztreonam | 76.6% | 9.4% | 14% | 29.9% | 43.1% | 27% |
| Ertapenem | 85.4% | 10.4% | 4.2% | -- | -- | -- |
| Imipenem | 41.5% | 20.3% | 38.2% | 81.0% | 10.4% | 8.6% |
| Meropenem | 47.3% | 14.4% | 38.3% | 89.7% | 8.2% | 2.1% |
| Gentamicin | 59.3% | 3.5% | 37.2% | 74.6% | 8.2% | 17.2% |
| Amikacin | 23.1% | 6.9% | 70% | 58.2% | 9.7% | 32.1% |
| Ciprofloxacin | 89.5% | 2% | 8.5% | 86.3% | 2.4% | 11.3% |
| Colistin | 12.7% | 0.2% | 87.1% | 5.4% | 0.3% | 94.3% |